Peripheral blood mononuclear cell proliferative responses to soluble and particulate heat shock protein 65 in health and inflammatory bowel disease

Objectives: The aims of this study were to determine, in peripheral blood mononuclear cells (PBMC), whether particulate antigen triggers (i) an amplified cell proliferative response compared to soluble antigen and (ii) a dysfunctional response in cells derived from patients with chronic inflammation and specifically in those with inflammatory bowel disease (IBD). Subjects: Healthy volunteers (n = 17), inflammatory controls (n = 8) and patients with IBD (n = 17) were recruited from St Thomas’ and Guys’ Hospital, London, UK. Methods: Following optimisation of experimental conditions (0.1–10.0 μg/ml antigen), PBMC were stimulated with (i) 10.0 μg/ml recombinant soluble heat shock protein 65 (hsp 65) and (ii) 1.0 and 10.0 μg/ml hsp 65 conjugated to microparticles (0.5 μm diameter). PBMC proliferative responses were measured by ³H-Thymidine incorporation at day 5 and results compared between groups using unpaired t-test. Results: Conjugation to microparticles of low dose hsp 65 significantly increased overall proliferative responses by 2–11 fold compared to soluble antigen alone (p < 0.05). However, no specific PBMC proliferative dysregulation was noted in cells from subjects with IBD. Conclusions: Low dose antigen, in microparticulate form, leads to amplified cell proliferation in primary human cells, as showed previously in cell lines and animal studies. However there is no abnormal proliferative response in cells from subjects with IBD. Received 8 February 2006; returned for revision 7 March 2006; accepted by G. Wallace 25 October 2006     

血清淀粉样P成分的DNA结合特性

目的 检测血清淀粉样P成分(SAP)与不同DNA的结合活性并研究SAP与DNA的结合是否有利于此类抗原的清除，探讨它在SLE发生发展中的作用及意义。方法 用亲和层析和凝胶过滤方法自小鼠和人血清中纯化SAP，分别提取来自细菌、质粒、酵母、小鼠淋巴细胞等不同DNA，用DOT-EIA方法检测SAP与它们的结合活性，用巨噬细胞吞噬实验观察SAP与DNA结合后对DNA清除的影响。结果 人和小鼠SAP均与细菌DNA结合最强，其次为质粒、酵母DNA，与淋巴细胞DNA和小牛胸腺DNA的结合较弱，与单链λDNA结合最弱；与来源于活化状态小鼠淋巴细胞DNA的结合力高于非活化状态；SAP与活化淋巴细胞DNA结合后可促进巨噬细胞对DNA的吞噬。结论 SAP与不同DNA结合活性各异。     

成年大鼠胰岛的体外基因转染

目的 探讨携带外源基因的慢病毒在体外有效感染胰岛及外源基因在胰岛中的表达，为通过移植前向胰岛细胞转入特定的免疫调节分子基因诱导胰岛移植物耐受奠定基础。方法 将目的基因CTLA4Ig导入慢病毒载体pWPTS，构建成pWPTS-CTLA4Ig载体。用磷酸钙沉淀法将pWPTS-EGFP、pWPTS-CTLA4Ig分别和其辅助载体pMD2．G、pCMVΔ8．92共转染293T细胞，收获病毒上清液，测定病毒滴度后感染新分离的胰岛。通过Western Blot测定胰岛培养上清液中CTLA4Ig蛋白的表达。结果 ①成功构建了携带CTLA4Ig基因的慢病毒载体pWPTS-CTLA4Ig；②包装产生的慢病毒Lenti-EGFP、Lenti-CTLA4Ig在体外可以感染胰岛，其中在Lenti-EGFP慢病毒感染的胰岛观察到了绿色荧光，及在Lenti-CTLA4Ig慢病毒感染的胰岛培养上清液中检测到了CTLA4Ig蛋白的表达。结论 慢病毒在体外可以有效感染大鼠胰岛，且携带的外源基因可以在胰岛细胞中稳定表达，其中Lenti-CTLA4Ig慢病毒感染的胰岛为进行胰岛移植并诱导体内特异的胰岛移植物耐受奠定了基础。     

建立一种用重组蛋白检测抗口蹄疫病毒抗体的间接ELISA方法

目的研究以重组蛋白作为包被抗原检测口蹄疫病毒（FMDV）感染后的动物血清中特异性抗体的可能性,为建立一种非病毒颗粒的ELISA检测试剂盒提供实验依据。方法利用自行构建表达的O型口蹄疫病毒VP1表位肽重组蛋白（VP1epi）作为包被抗原,采用间接ELISA方法确定抗原的最佳工作浓度和包被方法,优化各项实验条件,并以FMDV感染后的豚鼠血清作为标准阳性血清确定ELISA方法的特异性和灵敏度。结果FMDV感染后的阳性豚鼠血清可以很好地识别VP1epi重组蛋白,用此蛋白包被检测抗FMDV抗体的灵敏度可达1∶3200,并证明所检测的抗体是FMDV特异性的。结论VP1epi重组蛋白可以替代FMDV颗粒用于建立检测抗FMDV抗体的ELISA试剂盒。     

恒河猴骨髓间充质干细胞分离培养及其生长特性

采用密度梯度离心和贴壁筛选方法分离纯化了恒河猴骨髓间充质干细胞(mesenchymal stem cells from bone marrow of Rhesus monkey,RhBMSCs);通过表面抗原检测和核型分析对细胞进行了初步鉴定;通过生长曲线的绘制和细胞凋亡的检测探讨了细胞的生长特点。本实验获得的RhBMSCs形态以梭型为主,核型正常,CD29表达率为99.2%,CD34、CD45、HLA-DR表达率均低于3.2%,RhBMSCs表型符合间充质干细胞的特点,且纯度较高,细胞生长旺盛,但倍增时间有随传代数的增加而逐渐延长的趋势。本实验探讨了RhBMSCs的体外分离、扩增培养及鉴定的方法,并对其生长特点进行了初步观察,这不仅有助于进一步了解与之近似的人的骨髓间充质干细胞的相关特性,而且为以猕猴为对象的BMSC定向分化和组织修复等动物体内实验打下了基础。     

急性分离的大鼠骶髓后连合核神经元由抑制性氨基酸诱导的电流反应(英文)

应用制霉菌素穿孔全细胞电压钳技术．在急性分离的大鼠骶髓后连合核（SDCN）神经元上，研究抑制性氨基酸诱导的反应的电生理学和药理学特性。当钳制电压为-40mV时，γ-氨基丁酸（GABA）、甘氨酸（Gly）和牛磺酸（Tau）均诱导产生内向电流。它们的EC50值分别是GABA5．2×10-5M，Gly4．0×10-5M及Tau1．6×10-4M。其Hill系数分别为GABA1．21，Gly1．27和Tau1．23。所有这些电流均在膜电位为-1．8mV左右时翻转。此外．Tau和Gly反应问还存在很强的交叉脱敏。结果提示，GABAA，Gly和Tau作为递质，通过受体Cl-通道复合体．在调节SDCN社经元伤害性传递中可能有重要作用。     

乙酰胆碱酯酶阳性神经元在鼠脑的分布和形态特征

本文用乙酰胆碱酯酶(AChE)再生技术,研究AChE阳性神经元在鼠脑的分布和形态特征。按其染色程度,可见强度、中度和轻度三种染色细胞。强染色细胞多数是较大的多极细胞,主要分布于纹状体、基底前脑、下丘脑、黑质、红核、蓝斑,腹侧被盖区、臂旁核、桥被盖核和脑神经运动核。本文将AChE染色结果和胆碱乙酰转移酶(ChAT)免疫组织化学资料进行了比较,对AChE和胆碱能神经元的关系,以及AChE阳性神经元的性质和意义,进行了讨论。     

Stimulation by hCRF of C-peptide release in type 2 diabetics during concomitant opioid receptor blockade

Summary Administration of synthetic human corticotropin-releasing factor (hCRF, 2 µg/kg body weight) during simultaneous application of the opioid antagonist naloxone (1.6 mg i.v. bolus, followed by an infusion at a rate of 1.2 mg/h) produced a significant increase in plasma C-peptide levels of six male Type 2 diabetic patients which even exceeded the postprandial values. This stimulatory effect of hCRF/naloxone on plasma C-peptide was less pronounced in six healthy men. hCRF alone did not provoke any reaction of plasma C-peptide in either group.The possibility of a paracrine, CRF-dependent mechanism in pancreatic islets which somehow involves inhibitory opioid receptors is preferentially discussed. Such a mechanism may underlie the stimulatory action of hCRF/naloxone on B cells and would explain the absent reaction of peripheral venous plasma C-peptide to hCRF alone as well as the amplifying effect of simultaneous opioid receptor blockade.Abbreviations ACTH adrenocorticotropic hormone - C-peptide connecting-peptide - CRF corticotropin-releasing factor - hCRF human CRF - oCRF ovine CRF - min minutes - S.D. standard deviation - S.E.M. standard error of the mean This study was supported by the Deutsche Forschungsgemeinschaft (Go 299/3-2)Dedicated to Professor Dr. N. Zöllner on the occasion of his 65th birthday     

Macrophage antitumor activity in vitro. Comparative analysis of cytolytic, cytostatic, and cytotoxic activities of mouse macrophages and human monocytes

Mouse peritoneal M phi and human blood monocytes were assayed for their antitumor activity in vitro with a cytolysis, a cytostasis and a cytotoxicity test performed in parallel. Both natural and stimulus-induced M phi antitumor capacities were assessed. Results indicate that natural cytolytic activity of unstimulated M phi is generally unable to restrict final tumor cell growth, since it is not coupled with cytostatic capacity. In contrast, exposure of M phi in vitro to either MAF or IFN-beta, besides augmenting M phi cytolytic capacity, induced a very significant cytostatic activity and thus efficiently restricted the survival of tumor cells.     

Some studies on the mechanism of action of antibodies to nerve growth factor.

The effects of antibodies to the nerve growth factor from mouse salivary gland were examined in vitro and in vivo. Treatment of explants of receptive ganglia with antibody and complement did not produce cell damage as judged by the ability of the tissue to respond to nerve growth factor. New-born mice experimentally depleted of or genetically deficient in key complement components were susceptible to the action of the antiserum.These results show that the effect of the antibody is independent of complement and are consistent with the view that it acts by neutralization of endogenous nerve growth factor.